SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. 1
    Malcolm Maclure, Case–Crossover Designs for More Patient-Centred Epidemiology, Paediatric and Perinatal Epidemiology, 2014, 28, 2
  2. 2
    Marta Avalos, Ludivine Orriols, Hélène Pouyes, Yves Grandvalet, Frantz Thiessard, Emmanuel Lagarde, Variable selection on large case-crossover data: application to a registry-based study of prescription drugs and road traffic crashes, Pharmacoepidemiology and Drug Safety, 2014, 23, 2
  3. 3
    Peter Tugwell, J. André Knottnerus, Leanne Idzerda, A proposal for a new design: the exposure–crossover design, Journal of Clinical Epidemiology, 2013, 66, 9, 943

    CrossRef

  4. 4
    Guilherme Borges, Cheryl Cherpitel, Ricardo Orozco, Scott MacDonald, Norman Giesbrecht, Jacek Moskalewicz, Grazyna Swiatkiewicz, Mariana Cremonte, Alcohol as a Trigger for Medical Emergencies, Substance Use & Misuse, 2013, 48, 7, 484

    CrossRef

  5. 5
    Yu Ye, Jason Bond, Cheryl J. Cherpitel, Tim Stockwell, Scott Macdonald, Jürgen Rehm, Risk of Injury Due to Alcohol, Epidemiology, 2013, 24, 2, 240

    CrossRef

  6. 6
    Donald A. Redelmeier, The exposure-crossover design is a new method for studying sustained changes in recurrent events, Journal of Clinical Epidemiology, 2013, 66, 9, 955

    CrossRef

  7. 7
    Silvia Ravera, Nienke Rein, Johan J. Gier, Lolkje T. W. Jong-van den Berg, A comparison of pharmacoepidemiological study designs in medication use and traffic safety research, European Journal of Epidemiology, 2012, 27, 6, 473

    CrossRef

  8. 8
    Petra C. Koopmans, Jens H.J. Bos, Lolkje T.W. de Jong van den Berg, Are antibiotics related to oral combination contraceptive failures in the Netherlands? A case-crossover study, Pharmacoepidemiology and Drug Safety, 2012, 21, 8
  9. 9
    Chang-Hsing Lee, Jung-Der Wang, Pau-Chung Chen, Case–crossover design: an alternative strategy for detecting drug-induced liver injury, Journal of Clinical Epidemiology, 2012, 65, 5, 560

    CrossRef

  10. You have free access to this content10
    Joshua J. Gagne, Bruce Fireman, Patrick B. Ryan, Malcolm Maclure, Tobias Gerhard, Sengwee Toh, Jeremy A. Rassen, Jennifer C. Nelson, Sebastian Schneeweiss, Design considerations in an active medical product safety monitoring system, Pharmacoepidemiology and Drug Safety, 2012, 21,
  11. 11
    Hanna Hultin, Jette Möller, Kristina Alexanderson, Gun Johansson, Christina Lindholm, Ingvar Lundberg, Johan Hallqvist, Low Workload as a Trigger of Sick Leave, Journal of Occupational and Environmental Medicine, 2012, 54, 2, 202

    CrossRef

  12. You have free access to this content12
    Malcolm Maclure, Bruce Fireman, Jennifer C. Nelson, Wei Hua, Azadeh Shoaibi, Antonio Paredes, David Madigan, When should case-only designs be used for safety monitoring of medical products?, Pharmacoepidemiology and Drug Safety, 2012, 21,
  13. 13
    Jennifer M. Nicholas, Andrew P. Grieve, Martin C. Gulliford, Within-person study designs had lower precision and greater susceptibility to bias because of trends in exposure than cohort and nested case–control designs, Journal of Clinical Epidemiology, 2012, 65, 4, 384

    CrossRef

  14. 14
    Dong-Yoon Kang, Soyoung Park, Chul-Woo Rhee, Ye-Jee Kim, Nam-Kyong Choi, Joongyub Lee, Byung-Joo Park, Zolpidem Use and Risk of Fracture in Elderly Insomnia Patients, Journal of Preventive Medicine and Public Health, 2012, 45, 4, 219

    CrossRef

  15. 15
    Joongyub Lee, Nam-Kyoung Choi, Sun-Young Jung, Ye-Jee Kim, Jong-Mi Seong, Seung-June Oh, Byung-Joo Park, The Risk of Fracture with Taking Alpha Blockers for Treating Benign Prostatic Hyperplasia, Journal of Preventive Medicine and Public Health, 2009, 42, 3, 165

    CrossRef

  16. 16
    Malcolm Maclure, Murray A. Mittleman, Case-Crossover Designs Compared With Dynamic Follow-up Designs, Epidemiology, 2008, 19, 2, 176

    CrossRef

  17. 17
    Current awareness: Pharmacoepidemiology and drug safety, Pharmacoepidemiology and Drug Safety, 2007, 16, 12